Improving diagnosis and treatment of rare pediatric viral diseases
Administrative Core
This study is all about finding better ways to diagnose and treat rare viral infections in babies, like congenital CMV, neonatal herpes, and enterovirus sepsis, so that doctors can help these little ones more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10915384 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding and management of rare pediatric viral diseases, particularly congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus sepsis. By gathering and analyzing data from multiple sites, the project aims to improve diagnosis, clinical trial readiness, and treatment options for affected children. The administrative core will oversee coordination and communication among various research sites to ensure effective collaboration and resource management.
Who could benefit from this research
Good fit: Ideal candidates for participation are newborns diagnosed with congenital CMV, neonatal HSV infection, or neonatal enterovirus sepsis.
Not a fit: Patients with viral infections not covered by the study, or those outside the neonatal age range, may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatment strategies for rare viral infections in newborns, ultimately reducing disease burden.
How similar studies have performed: Previous research has shown success in improving outcomes for pediatric viral diseases through collaborative data collection and analysis, indicating a promising approach.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Kimberlin, David W — University of Alabama at Birmingham
- Study coordinator: Kimberlin, David W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.